<DOC>
	<DOCNO>NCT00615589</DOCNO>
	<brief_summary>Standard therapy multiple myeloma ( MM ) usually include autologous bone marrow stem cell transplant - procedure patient treat high dose chemotherapy ( autologous ) stem cell transplant back body . Patients multiple myeloma high risk gene , always relapse autologous transplant often die within two year time transplant . A different type transplant allogeneic ) use donor cell , may work good high-risk Multiple Myeloma , donor cell may help kill lymphoid cancer cell . This study investigate match donor stem cell transplant use new , reduced toxicity , chemotherapy ( Flu-Bu4 ) feasible option patient high risk , Multiple Myeloma .</brief_summary>
	<brief_title>Stem Cell Transplantation To Treat High Risk Multiple Myeloma With Reduced Toxicity Myeloablative Conditioning Regimen</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Leukemia , Plasma Cell</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Busulfan</mesh_term>
	<criteria>Biologic high risk Multiple Myeloma : Stage II/III Multiple Myeloma , : ( 4 ; 14 ) , ( 14 ; 16 ) , ( 14:20 ) Fish ; 17P conventional cytogenetics Fish ; âˆ†13 conventional cytogenetics ; Hypodiploidy conventional cytogenetics . Relapsed persistent multiple myeloma ASCT . Persistent multiple myeloma , regardless previous therapy . Plasma cell leukemia , regardless previous therapy . Age 70 year old ( less 71 year old date transplant admission ) . Disease status : CR , nCR , VGPR , PR stable disease within 1 month admission Patients nonsecretory oligosecretory disease eligible meet certain criterion within 2 week prior transplant . Specific renal , liver , cardiac , pulmonary function requirement ( must meet within 30 day transplant admission ) Persistent invasive infection , control antimicrobial . HIV1/HIV2 HTLV1/HTLV2 seropositivity . Uncontrolled medical psychiatric disorder . No response progressive disease time transplantation . Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Stage II/III Multiple Myeloma ( within 10 month diagnosis )</keyword>
	<keyword>high risk</keyword>
	<keyword>relapse</keyword>
	<keyword>persistent</keyword>
</DOC>